Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Bellerophon Therapeutics (BLPH) Insider Trading & Ownership

Bellerophon Therapeutics logo

Bellerophon Therapeutics (NASDAQ:BLPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.20%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
3
Amount Of
Insider Selling
(Last 3 Years)
$5.61M
Get BLPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bellerophon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BLPH Insider Buying and Selling by Quarter

Bellerophon Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/13/2023
Puissance Capital Management L
Major Shareholder
Sell1,076,841$0.10$107,684.10  
6/7/2023
Life Science Opportu Puissance
Major Shareholder
Sell134,421$0.83$111,569.43  
5/18/2023
Bobae Kim
VP
Sell9,455$10.00$94,550.00  
5/18/2023
Life Science Opportu Puissance
Major Shareholder
Sell560,000$9.46$5,297,600.00  
(Data available from 1/1/2013 forward)

BLPH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bellerophon Therapeutics includes Bobae Kim, Life Science Opportu Puissance, and Puissance Capital Management L. Learn more on insiders at BLPH.

5.20% of Bellerophon Therapeutics stock is owned by insiders. Learn more on BLPH's insider holdings.



This page (NASDAQ:BLPH) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners